CMB — Cambium Bio Cashflow Statement
0.000.00%
Last trade - 00:00- AU$8.41m
- AU$8.73m
- AU$0.67m
Annual cashflow statement for Cambium Bio, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.567 | 0.829 | 1.05 | 0.487 | 0.029 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.42 | -3.59 | -0.66 | -0.156 | -5.24 |
| Capital Expenditures | -0.008 | -0.008 | — | — | -0.005 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | -0.048 | -0.416 | -0.328 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.008 | -0.008 | -0.048 | -0.416 | -0.333 |
| Financing Cash Flow Items | 1.5 | -1.29 | -0.031 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.4 | -0.098 | 0.916 | 3.13 | 2.88 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.81 | -3.7 | 0.208 | 2.56 | -2.7 |